Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
Clinical trial NCT05045482 · RECRUITING
Trial details
- NCT number
- NCT05045482
- Sponsor
- Zydus Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-21
- Primary completion
- 2026-07-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.